3,616
Views
98
CrossRef citations to date
0
Altmetric
Original Articles

Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Substance Dependence—Qualitative Results

, Dipl.-Psych., Ph.D. & , M.D., Dipl.-Psych.

REFERENCES

  • Bouso, J.C.; González, D.; Fondevila, S.; Cutchet, M.; Fernández, X.; Ribeiro Barbosa, P.C.; Alcázar-Corcoles, M.A.; Araújo, W.S.; Barbanoj, M.; Fábregas, J.M. & Riba, J. 2012. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: A longitudinal study. PLOS ONE 7 (8): e42421.
  • Brierley, D. & Davidson, C. 2012. Developments in harmine pharmacology: Implications for ayahuasca use and drug-dependence treatment. Progress in Neuropsychopharmacology & Biological Psychiatry 39: 263–72.
  • Bustos, S. 2008. The Healing Power of the Icaros: A Phenomenological Study of Ayahuasca Experiences. San Francisco, CA: The California Institute of Integral Studies.
  • Calabrese, J.D. 2013. A Different Medicine: Postcolonial Healing in the Native American Church. New York: Oxford University Press.
  • Callaway, J.C. & Grob, C.S. 1998. Ayahuasca preparations and serotonin reuptake inhibitors: A potential combination for severe adverse interactions. Journal of Psychoactive Drugs 30 (4):367–9.
  • Callaway, J.C.; McKenna, D.J.; Grob, C.S.; Brito, G.S.; Raymon, L.P.; Poland, R.E.; Andrade, E.N. & Mash, D.C. 1999. Pharmacokinetics of hoasca alkaloids in healthy humans. Journal of Ethnopharmacology 65: 243–56.
  • Chiappe Costa, M. 1979. El empleo de alucinógenos en la psiquiatría folklórica. In: C.A. Seguin (Ed.) Psiquiatría Folklórica: Shamanes y Curanderos. Lima, Peru: Edición Centro de Proyección Cristiana.
  • Denys, A. 2005. Alliance des Medecines Occidentales et Traditionnelles dans le Traitement des Addictions. Nancy, France: Université Henri Poincaré.
  • Dobkin de Rios, M. 1972. Visionary Vine: Psychedelic Healing in the Peruvian Amazon. San Francisco, CA: Chandler.
  • Doering-Silveira, E.; Grob, C.S.; Dobkin de Rios, M.; Lopez, E.; Alonso, L.K.; Tacla, C. & da Silviera, D.X. 2005. Report on psychoactive drug use among adolescents using ayahuasca within a religious context. Journal of Psychoactive Drugs 37 (2): 141–4.
  • Fábregas, J.M.; González, D.; Fondevila, S.; Cutchet, M.; Fernández, X.; Barbosa, P.C.; Alcázar-Córcoles, M.Á.; Barbanoj, M.J.; Riba, J. & Bouso, J.C. 2010. Assessment of addiction severity among ritual users of ayahuasca. Drug and Alcohol Dependence 111 (3): 257–61.
  • Fernández, X. & Fábregas, J.M. 2013. Experiencia de un tratamiento con ayahuasca para los drogodepenencias en la Amazonia Brasilieña. In: B.C. Labate & J.C. Bouso (Eds.) Ayahuasca y Salud. Barcelona, Spain: Los Libros de La Liebre de Marzo.
  • Fiedler, L.; Jungaberle, H. & Verres, R. 2011. Motive für den Konsum psychoaktiver Substanzen am Beispiel des Ayahuasca-Gebrauchs in der Santo-Daime Gemeinschaft. Zeitschrift für Medizinische Psychologie 3/2011 (20): 137–44.
  • Gable, R.S. 2007. Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102 (1): 24–34.
  • Giove Nakazawa, R.A. 2002. La Liana de los Muertos al Rescate de la Vida: Medicina Tradicional Amazónica en el Tratamiento de Toxicomanías. Tarapoto, Peru: Revista Takiwasi.
  • Grob, C.; McKenna, D.J.; Callaway, J.C.; Brito, G.S.; Neves, E.S.; Oberlaender, G.; Saide, O.L.; Labigalini, E.; Tacla, C.; Miranda, C.T.; Strassman, R.J. & Boone, K.B. 1996. Human psychopharmacology of hoasca: A plant hallucinogen in ritual context in Brazil. The Journal of Nervous and Mental Disease 184 (2): 86–94.
  • Grof, S. 1980. LSD Psychotherapy. Pomona, CA: Hunter House.
  • Groisman, A. & Dobkin de Rios, M. 2007. Ayahuasca, the U.S. Supreme Court, and the UDV–U.S. government case: Culture, religion, and implications of a legal dispute. In: M.J. Winkelman & T.B. Roberts (Eds.) Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Westport, CT: Praeger.
  • Guimarães dos Santos, R. 2013. Safety and side effects of ayahuasca in humans: An overview focusing on developmental toxicology. Journal of Psychoactive Drugs 45 (1): 68–78.
  • Halpern, J.H. 1996. The use of hallucinogens in the treatment of addictions. Addiction Research and Theory 4 (2): 177–89.
  • Halpern, J.H. 2007. Hallucinogens in the treatment of alcoholism and other addictions. In: M.J. Winkelman & T.B. Roberts (Eds.) Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Westport, CT: Praeger.
  • Halpern, J.H.; Sherwood, A.R.; Passie, T.; Blackwell, K.C. & Ruttenber, A.J. 2008. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Medical Science Monitor 14 (8): 15–22.
  • Hämmig, R. 2008. Psychedlika-unterstützte Suchttherapien. In: H. Jungaberle, P. Gasser, J. Weinhold & R. Verres (Eds.) Therapie mit Psychoaktiven Substanzen. Bern, Switzerland: Huber.
  • Hermle, L. 2008. Risiken und nebenwirkungen von LSD, Psilocybin und MDMA in der psychotherapie. In: H. Jungaberle, P. Gasser, J. Weinhold & R. Verres (Eds.) Therapie mit Psychoaktiven Substanzen. Bern, Switzerland: Huber.
  • Instituto Nacional de Cultura. 2008. Declaración Patrimônio Cultural de la nación a los conocimientos y usos tradicionales de la ayahuasca praticados por comunidades nativas amazónicas (Resolución Directoral Nacional No. 836), June 24, Lima, Peru.
  • Jungaberle, H.; Gasser, P.; Weinhold, J. & Verres, R. (Eds.) 2008. Therapie mit Psychoaktiven Substanzen: Praxis und Kritik der Psychotherapie mit LSD, Psilocybin und MDMA. Bern, Switzerland: Huber.
  • Krebs, T.S. & Johansen, P.O. 2012. Lysergic acid dietthylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. Psychopharmacology 26 (7): 994–1002.
  • Kvale, S. & Brinkmann, S. 2009. InterViews: Learning the Craft of Qualitative Research Interviewing. Thousand Oaks, CA: Sage.
  • Labate, B.C. & Feeney, K. 2012. Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. International Journal of Drug Policy 23: 154–61.
  • Labate, B.C.; Guimaraes dos Santos, R.; Strassman, R.; Anderson, B. & Mizumoto, S. 2013. Efectos de la afiliación al Santo Daime sobre la dependencia a sustancias. In: B.C. Labate & J.C. Bousco (Eds.) Ayahuasca y Salud. Barcelona, Spain: Los Libros de la Liebre de Marzo.
  • Labate, B.C. & Jungaberle, H. (Eds.) 2011. The Internationalization of Ayahuasca. Zurich, Switzerland: LIT Verlag.
  • Labate, B.C. & MacRae, E. 2010. Ayahuasca, Ritual, and Religion in Brazil. London: Equinox.
  • Labate, B.C.; Santos, R.G.; Anderson, B.T.; Mercante, M. & Barbosa, P.C.R. 2010. The treatment and handling of substance dependency with ayahuasca: Reflections on current and future research. In: B.C. Labate & E. MacRae (Eds.) Ayahuasca, Ritual, and Religion in Brazil. London: Equinox.
  • Labigalini, E. 1998. O Uso de Ayahuasca em um Contexto Religioso por Ex-dependentes de Álcool: Um Estudo Qualitativo. Sao Paulo, Brazil: Universidade Federal de Sâo Paulo.
  • Lamnek, S. 2005. Qualitative Sozialforschung. Weinheim, Germany: Beltz.
  • Liester, M.B. & Prickett, J. 2012. Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions. Journal of Psychoactive Drugs 44 (3): 200–8.
  • Loizaga-Velder, A. 2013. A psychotherapeutic view on therapeutic effects of ritual ayahuasca use in the treatment of addiction. MAPS Bulletin 23 (1): 36–40.
  • Luna, L.E. 1986. Vegetalismo: Shamanism among the Mestizo Population of the Peruvian Amazon. Stockholm: Almqvist & Wiksell.
  • Luna, L.E. 2011. Indigenous and mestizo use of ayahuasca: An overview. In: R. Guimarães dos Santos (Ed.) The Ethnopharmacology of Ayahuasca. Trivandrum, India: Transworld Research Network.
  • Mabit, J. 2007. Ayahuasca in the treatment of addictions. In: M.J. Winkelman & T.B. Roberts (Eds.) Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Westport, CT: Praeger.
  • Mangini, M. 1998. Treatment of alcoholism using psychedelic drugs: A review of the program of research. Journal of Psychoactive Drugs 30 (4): 381–418.
  • McKenna, D.J.; Callaway, J.C. & Grob, C.S. 1999. The scientific investigation of ayahuasca: A review of past and current research 1998. The Heffter Review of Psychedelic Research 1: 65–76.
  • McKenna, D.; Luna, L.E. & Towers, G.H. 1995. Biodynamic constitutents in ayahuasca admixture plants. In: S. von Reis & R.E. Schultes (Eds.) Ethnobotany: Evolution of a Discipline. Portland, OR: Dioscorides Press.
  • Mercante, M. 2009. Ayahuasca: dependência química e alcoolismo. Ponto Urbe 5: 1–23.
  • Miles, M.B. & Huberman, A.M. 1994. Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA: Sage.
  • Passie, T. 2007. Contemporary psychedelic therapy: An overview. In: M.J. Winkelman & T.B. Roberts (Eds.) Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Westport, CT: Praeger.
  • Patton, M.Q. 2002. Qualitative Research and Evaluation Methods. Thousand Oaks, CA: Sage.
  • Pfitzner, F. 2008. Amazonische Heilkunde in der Behandlung der Drogensucht: Eine Explorative Studie. Saarbrücken, Germany: Verlag Dr. Müller.
  • Presser-Velder, A. 2000. Das Therapeutische Potential der Rituellen Verwendung Sakraler Heilpflanzen Psychology. Landau, Germany: University of Koblenz/Landau.
  • Presser-Velder, A. 2013. Treating substance dependencies with psychoactives: A theoretical and qualitative empirical study on therapeutic uses of ayahuasca. Dissertation, Institute for Medical Psychology, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany.
  • Riba, J.; Anderer, P.; Morte, A.; Urbano, G.; Jané, F.; Saletu, B. & Barbanoj, M.J. 2002. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. British Journal of Clinical Pharmacology 53 (6): 613–28.
  • Riba, J. & Barbanoj, M. 2005. Bringing ayahuasca into the research laboratory. Journal of Psychoactive Drugs 37 (2): 219–30.
  • Riba, J. & Bouso, J.C. 2011. An overview of the literature on the pharmacology and neuropsychiatric long term effects of ayahuasca. In: R. Guimarães dos Santos (Ed.) The Ethnopharmacology of Ayahuasca. Trivandrum, India: Transworld Research Network.
  • Santos, R.G.; Carvalho de Moraes, C. & Holanda, A. 2006. Ayahuasca e reduçâo do uso abusivo de psicoativos: Eficácia terapêutica? Psicologia: Teoria e Pesquisa 22 (3): 363–70.
  • Savinelli, A. & Halpern, J.H. 1995. MAOI contraindications. MAPS Bulletin 6 (1): 58.
  • Schmid, J. 2008. Subjektive Theorien zu Selbst-Behandlungsversuchen mit der Psychoaktiven Substanz Ayahuasca. Heidelberg, Germany: Ruprechts-Karls-Universität.
  • Schwarz, M.J.; Houghton, P.J.; Rose, S.; Jenner, P. & Lees, A.D. 2003. Activities of extracts and constituents of Banisteriopsis caapi relevant to Parkinsonism. Pharmacology, Biochemistry, and Behavior 75 (3): 627–33.
  • Thesenga, S. & Thesenga, P. 2012. Love Unbroken: From Addiction to Redemption. Charlottesville, VA: Being and Awakening.
  • Thomas, G.; Lucas, P.; Capler, R.; Tupper, K. & Martin, G. 2013. Ayahuasca-assisted therapy for addictions: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews 6 (1): 30–42.
  • Tupper, K. 2008. The globalization of ayahuasca: Harm reduction or benefit maximization? The International Journal of Drug Policy 19 (4): 297–303.
  • Tupper, K. & Labate, B. 2012. Plants, psychoactive substances and the International Narcotics Control Board: The control of nature and the nature of control. Human Rights & Drugs 2 (1): 17–28.
  • U.S. Department of Health and Human Services; National Institutes of Health & National Institute of Drug Abuse. 2009. Principles of Drug Addiction Treatment: A Research Based Guide. Bethesda, MD: U.S. Department of Health and Human Services.
  • Vollenweider, F. 2008. Neurobiologie der halluzinogenerfahrung. In: H. Jungaberle, P. Gasser, J. Weinhold & R. Verres (Eds.) Therapie mit Psychoaktiven Substanzen. Bern, Switzerland: Huber.
  • Witzel, A. 2000. The problem centered interview. Forum Qualitative Social Research 1 (1): Article 22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.